Toggle menu
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.
Revision as of 23:27, 15 May 2026 by Maintenance script (talk | contribs) (Pendell's corner: verbatim (Dynamis, p. 29))
Xanthine, Stimulant
Caffeine

Experience

👥 No personal reports yet
No clinical reports yet

Log in to add your own experience.

Problems

No problems yet. Be the first to suggest one.

+ Add a problem

Titration strategies

No titration strategies yet. Be the first to suggest one.

+ Add a titration strategy

Effects

No effects listed yet. Be the first to suggest one.

+ Add an effect

Interactions

Pharmacogenomic + mechanism interactions2 edges
Pharmacokinetic mechanismSubstrate / metabolism relationships from primary literature
Enzyme:CYP1A2 substrate major Primary 80 / 100
FDA Drug Interactions Table: sensitive index substrate of CYP1A2.
Inferred from pharmacokinetic dataMaterialised by the inference engine; provenance shown per row
Fluvoxamine pk raises via CYP1A2 Inferred 72 / 100
Fluvoxamine inhibits CYP1A2 (inhibitor_strong, intensity 90); Caffeine is a substrate_major of CYP1A2 (intensity 80). Derived: Caffeine exposure raised.
Inferred via Enzyme:CYP1A2 (exposure raised)

Patient experience

No patient-experience reports yet.

Relevant anecdote

No anecdotes yet. Share a relevant one.

+ Add an anecdote

Relevant Literature

No literature entries yet.

Log in to submit relevant literature.

Summary
Classes
Xanthine, Stimulant
Common uses
Pharmacy
Pharmacology
Purported mechanism
Adenosine receptor antagonist


Pendell's corner
Caffeine is a central nervous system stimulant, a cardiac stimulant, a respiratory stimulant, and a diuretic. Caffeine is addictive. Withdrawal symptoms typically include irritability, fatigue, and headaches, sometimes severe.
— Dale Pendell, Pharmako/Dynamis, p. 29